US Archives - European Medical Journal

New Checklist Empowers Clinicians to Assess AI in Cancer Care

AI is rapidly transforming oncology, but many clinicians lack practical tools to evaluate its real-world reliability.

Unexpected Brain Shift Emerges in Oral Disorder

Coping behaviors that temporarily alleviate the distressing sensations of oral cenesthopathy are linked to paradoxical changes in brain perfusion, according to new neuroimaging research.

When Treating Asthma, Calming the Mind Matters Too

Psychological support combined with respiratory function training has been shown to reduce anxiety a

Advancements in Pediatric Lung Transplantation

Since pediatric lung transplantation (LTx) was first successfully performed in October 1987,1 it has become an established treatment for…

How Messaging Strategies Impact STI Vaccine Uptake

Vaccine acceptance for sexually transmitted infections (STIs) may depend heavily on the way recommendations are worded, according to new cross-sectional data from the USA, China, and Indonesia.

Surgeons Confront Complex Realities in Knee Pain Care

Surgeons treating patients with unexplained pain after knee arthroplasty face profound clinical and emotional challenges, according to a new qualitative study that highlights the complexity of decision-making in this setting.

US Study Maps Shifting ITP Mortality Trends

Immune thrombocytopenic purpura (ITP) mortality in the United States has persisted over the past two decades.

Interview: Susan Manzi

I always say that you have to think of lupus to diagnose it. There are a few facts that may help. Lupus tends to impact young women…

Chemotherapy Choice Drives Diarrhea Risk in Anal Cancer

Acute diarrhea during chemoradiotherapy for anal cancer is significantly more likely among patients treated with 5-fluorouracil (5-FU) or capecitabine compared with those receiving cisplatin or radiotherapy alone, according to new findings.

Updated Criteria Advance Vascular Dementia Diagnosis

Revised international diagnostic criteria have been introduced for vascular cognitive impairment and dementia (VCID), aiming to standardize assessment and improve consistency across clinical and research settings.